Open Access
Subscription or Fee Access
Aerobic Exercise Prescription in Chronic Obstructive Pulmonary Disease Patients Using Six-Minute Walk Test: A Narrative Review
Abstract
References
Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet.
;364(9435):70921. doi: 10.1016/S0140–6736(04)16900–6, PMID 15325838.
Torres M, Moayedi S. Evaluation of the acutely dyspneic elderly patient. Clin Geriatr Med. May
;23(2):307–25, vi. doi: 10.1016/j.cger.2007.01.007, PMID 17462519.
ATS [statement]. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care
Med. 2002;166(1):111–7. doi: 10.1164/ajrccm.166.1.at1102, PMID 12091180.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of
disease and risk factors, 2001: systematic analysis of population health data. Lancet.
;367(9524):1747–57. doi: 10.1016/S0140–6736(06)68770–9, PMID 16731270.
World Health Organization. World Health Rep. 2002: reducing risks, promoting healthy life.
Reddy KS, Gupta PC. Report on tobacco control in India. New Delhi: Ministry of Health and
Family Welfare, Government of India; 2004p. p. 99–102.
Akhtar MA, Latif PA. Prevalence of chronic bronchitis in urban population of Kashmir. J Indian
Med Assoc. 1999;97(9):365–6, 369. PMID 10638082.
Schellevis FG, Van de Lisdonk EH, Van der Velden J, Hoogbergen SH, Van Eijk JT, Van Weel
C. Consultation rates and incidence of intercurrent morbidity among patients with chronic disease
in general practice. Br J Gen Pract. 1994;44(383):25962. PMID 8037980.
Stoller JK, Aboussouan LS. Alpha 1antitrypsin deficiency. Lancet. 2005;365(9478):2225–36. doi:
1016/S0140–6736(05)66781–5, PMID 222536.
US surgeon general. The health consequences of smoking. Chronic Obstruct Pulm Dis. 1984.
Becklake MR. Occupational exposures: evidence for a causal association with chronic obstructive
pulmonary disease. Am Rev Respir Dis. 1989;140(3 Pt 2):S85–91. doi:
1164/ajrccm/140.3_Pt_2.S85, PMID 2675712.
Eisner MD, Balmes J, Katz PP, Trupin L, Yelin EH, Blanc PD. Lifetime environmental tobacco
smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health.
;4(1):7. doi: 10.1186/1476–069X-4–7, PMID 15890079.
Hnizdo E, Sullivan PA, Bang KM, Wagner G. Airflow obstruction attributable to work in industry
and occupation among U.S. race/ethnic groups: a study of NHANES III data. Am J Ind Med.
;46(2):12635. doi: 10.1002/ajim.20042, PMID 15273964.
Smith KR. Inaugural article: national burden of disease in India from indoor air pollution. Proc
Natl Acad Sci U S A. 2000;97(24), PMID 1328693.
Abbey DE, Burchette RJ, Knutsen SF, McDonnell WF, Lebowitz MD, Enright PL. Long-term
particulate and other air pollutants and lung function in nonsmokers. Am J Respir Crit Care Med.
;158(1):28998. doi: 10.1164/ajrccm.158.1.9710101, PMID 9655742.
Lawlor DA, Ebrahim S, Davey Smith G. Association of birth weight with adult lung function:
findings from the British Women’s Heart and Health Study and a meta-analysis. Thorax.
;60(10):851–8. doi: 10.1136/thx.2005.042408, PMID 16055617.
MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive
pulmonary disease. Proc Am Thorac Soc. 2005;2(1):50–60. doi: 10.1513/pats.200411–056SF,
PMID 16113469.
Silverman EK, Weiss ST, Drazen JM, Chapman HA, Carey V, Campbell EJ, Denish P, Silverman
R, Celedon J, Reilly J, Ginns L, Speizer F. Gender related differences in severe, early onset
chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162(6):21528. doi:
1164/ajrccm.162.6.2003112.Aerobic Exercise Prescription in Chronic Obstructive Pulmonary Disease Shahin Naz Jamali
© JournalsPub 2021. All Rights Reserved 14
Shaheen SO, Barker DJ, Shiell AW, Crocker FJ, Wield GA, Holgate ST. The relationship
between pneumonia in early childhood and impaired lung function in late adult life. Am J Respir
Crit Care Med. 1994;149(3 Pt 1):616–9. doi: 10.1164/ajrccm.149.3.8118627, PMID 8118627.
Prescott E, Lange P, Vestbo J. Socioeconomic status, lung function and admission to hospital for
COPD: results from the Copenhagen City Heart Study. Eur Respir J;1(999; 13 (5)). PMID
Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet.
;364(9435):70921. doi: 10.1016/S0140–6736(04)16900–6, PMID 15325838.
Birring SS, Brightling CE, Bradding P, Entwisle JJ, Vara DD, Grigg J, Wardlaw AJ, Pavord ID.
Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in
nonsmokers: a descriptive study. Am J Respir Crit Care Med. 2002;166(8):1078–83. doi:
1164/rccm.200203–245oc, PMID 12379551.
Birring SS, Brightling CE, Bradding P, Entwisle JJ, Vara DD, Grigg J, Wardlaw AJ, Pavord ID.
Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in
nonsmokers: a descriptive study. Am J Respir Crit Care Med. 2002;166(8):1078–83. doi:
1164/rccm.200203–245oc, PMID 12379551.
Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev.
;56(4):51548. doi: 10.1124/pr.56.4.2.
Stockley RA. Neutrophils and the pathogenesis of COPD. Chest. 2002;121(5);Suppl:151S5S. doi:
1378/chest.121.5_suppl.151s, PMID 12010844.
Barnes PJ. Alveolar Macrophages as orchestrators of COPD. COPD. J COPD. 2004;1(1):59–70.
doi: 10.1081/COPD-120028701, PMID 16997739.
Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM,
Sciurba FC, Coxson HO, Paré PD. The nature of small airway obstruction in chronic obstructive
pulmonary disease. N Engl J Med. 2004;350(26):2645–53. doi: 10.1056/NEJMoa032158, PMID
MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol.
;429(1–3):195–207. doi: 10.1016/s0014–2999(01)01320–6, PMID 11698041.
Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and
characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary
rehabilitation. Am Rev Respir Dis. 1993;147(5):1151–6. doi: 10.1164/ajrccm/147.5.1151, PMID
Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM,
Hogg JC, Barnes PJ. Decreased histone deacetylase activity in chronic obstructive pulmonary
disease. N Engl J Med. 2005;352(19):1967–76. doi: 10.1056/NEJMoa041892, PMID 15888697.
Simon PM, Schwartzstein RM, Weiss JW, Fencl V, Teghtsoonian M, Weinberger SE.
Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis.
;142(5):1009–14. doi: 10.1164/ajrccm/142.5.1009, PMID 2240820.
Elliott MW, Adams L, Cockcroft A, MacRae KD, Murphy K, Guz A. The language of
breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. Am Rev
Respir Dis. 1991;144(4):82632. doi: 10.1164/ajrccm/144.4.826, PMID 1928956.
Georgopoulas D, Anthonisen NR. Symptoms and signs of COPD. In: Cherniack NS, editor
Chronic obstructive pulmonary disease. Toronto: W B Saunders Company; 1991:35763.
Hill AT, Bayley D, Stockley RA. The interrelationship of sputum inflammatory markers in
patients with chronic bronchitis. Am J Respir Crit Care Med. 1999;160(3):893–8. doi:
1164/ajrccm.160.3.9901091, PMID 10471615.
Stockley RA, O’Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient
management of acute exacerbations of COPD. Chest. 2000;117(6):1638–45. doi:
1378/chest.117.6.1638, PMID 10858396.
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical
Research Council. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a
measure of disability in patients with chronic obstructive pulmonary disease. Thorax.
;54(7):581–6. doi: 10.1136/thx.54.7.581, PMID 10377201.International Journal of Cardiovascular Nursing
Volume 7, Issue 1
ISSN: 2581-7051
© JournalsPub 2021. All Rights Reserved 15
Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5year survival than
airway obstruction in patients with COPD. Chest. 2002;121(5):1434–40. doi:
1378/chest.121.5.1434, PMID 143440.
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical
Research Council. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a
measure of disability in patients with chronic obstructive pulmonary disease. Thorax.
;54(7):581–6. doi: 10.1136/thx.54.7.581, PMID 10377201.
Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE,
National Emphysema Treatment Trial Research Group. A randomized trial comparing lung
volume reduction surgery with medical therapy for severe emphysema. N Engl J Med.
;348(21):2059–73. doi: 10.1056/NEJMoa030287, PMID 12759479.
ATS [statement]. ATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care
Med. 2002;166(1):111–7. doi: 10.1164/ajrccm.166.1.at1102.
Poulain M, Durand F, Palomba B, Ceugniet F, Desplan J, Varray A, Préfaut C. Six-minute walk
testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation
in patients with COPD. Chest. 2003;123(5):1401–7. doi: 10.1378/chest.123.5.1401, PMID
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS
statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–
doi: 10.1164/ajrccm.166.1.at1102, PMID 12091180.
Srikanth AV, D’souza et al. Reference equations for the six minute walk distance in Indian
population. Chest/130/2006.
Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B,
Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F,
Morgan M, O’Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T,
ATS/ERS Pulmonary Rehabilitation Writing Committee. American Thoracic Society/European
Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med.
;173(12):1390–413. doi: 10.1164/rccm.200508–1211ST, PMID 16760357.
Foster S, Lopez D, Thomas HM III. Pulmonary rehabilitation in COPD patients with elevated
PCO2. Am Rev Respir Dis. 1988;138(6):1519–23. doi: 10.1164/ajrccm/138.6.1519, PMID
Borg G. Psychological bases of perceived exertion. Med Sci Sports Exer. 1982;14:377–81.
Fletcher GF, Balady G, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards.
A statement for healthcare professionals from the American Heart Association. Writing Group.
Circulation. 1995;91(2):580–615. doi: 10.1161/01.cir.91.2.580, PMID 7805272.
American College of Sports Medicine. The recommended quantity and quality of exercise for
developing and maintaining cardiorespiratory and muscular fitness in healthy adults(Position
Statement). Med Sci Sports Exerc. 1990;22(2):265–74. PMID 2355825.
Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA, Enright
PL, Kanner RE, O’Hara P, et al. Effects of smoking intervention and the use of an inhaled
anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA.
;272(19):1497–505, PMID 7966841.
Higgins BG, Powell RM, Cooper S, Tattersfield AE. Effect of salbutamol and ipratropium
bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. Eur Respir J.
;4(4):41520. PMID 1830277.
Gross NJ, Petty TL, Friedman M, Skorodin MS, Silvers GW, Donohue JF. Dose response to
ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A
three-center study. Am Rev Respir Dis. 1989;139(5):1188–91. doi: 10.1164/ajrccm/139.5.1188,
PMID 118891.
Shim CS, Williams MH, Jr. Bronchodilator response to oral aminophylline and terbutaline versus
aerosol albuterol in patients with chronic obstructive pulmonary disease. Am J Med.
;75(4):697–701. doi: 10.1016/0002–9343(83)90459-x, PMID 6624778.Aerobic Exercise Prescription in Chronic Obstructive Pulmonary Disease Shahin Naz Jamali
© JournalsPub 2021. All Rights Reserved 16
Disse B, Speck GA, Rominger KL, Witek TJ, Jr., Hammer R. Tiotropium (Spiriva): mechanistical
considerations and clinical profile in obstructive lung disease. Life Sci. 1999;64(6–7):45764. doi:
1016/s0024–3205(98)00588–8, PMID 10069510.
Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW,
Witek T. A long-term evaluation of once daily inhaled tiotropium in chronic obstructive
pulmonary disease. Eur Respir J. 2002;19(2):217–24. doi: 10.1183/09031936.02.00269802,
PMID 11866001.
Szafranski W, Cukier A, Ramirez A, Menga G, Sansores R, Nahabedian S, Peterson S, Olsson H.
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive
pulmonary disease. Eur Respir J. 2003;21(1):74–81. doi: 10.1183/09031936.03.00031402, PMID
van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C. Effect of
discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease:
the COPE study. Am J Respir Crit Care Med. 2002;166(10):1358–63. doi: 10.1164/rccm.200206–
OC, PMID 12406823.
Fabbri LM, Calverley PM, Izquierdo-Alonso JL, Bundschuh DS, Brose M, Martinez FJ, Rabe KF,
M2–127 and M2–128 study groups. M2–127 and M2–128 study groups. Roflumilast in moderateto-severe chronic obstructive pulmonary disease treated with long-acting bronchodilators: two
randomised clinical trials. Lancet. 2009;374(9691):695–703. doi: 10.1016/S0140–
(09)61252–6, PMID 19716961.
Behnke M, Taube C, Kirsten D, Lehnigk B, Jörres RA, Magnussen H. Homebased exercise is
capable of preserving hospital-based improvements in severe chronic obstructive pulmonary
disease. Respir Med. 2000;94(12):1184–91. doi: 10.1053/rmed.2000.0949, PMID 118491.
Ries AL, Kaplan RM, Myers R, Prewitt LM. Maintenance after pulmonary rehabilitation in
chronic lung disease: a randomized trial. Am J Respir Crit Care Med. 2003;167(6):880–8. doi:
1164/rccm.200204–318OC, PMID 12505859.
Engelen MP, Schols AM, Baken WC, Wesseling GJ, Wouters EF. Nutritional depletion in
relation to respiratory and peripheral skeletal muscle function in outpatients with COPD. Eur
Respir J. 1994;7(10):17937. doi: 10.1183/09031936.94.07101793, PMID 7828687.
Report of the Medical Research Council Working Party. Long-term domiciliary oxygen therapy
in chronic hypoxic corpulmonale complicating chronic bronchitis and emphysema Lancet.
;1(8222):6816
McEvoy RD, Pierce RJ, Hillman D, Esterman A, Ellis EE, Catcheside PG, O’Donoghue FJ,
Barnes DJ, Grunstein RR, Australian trial of non-invasive Ventilation in Chronic Airflow
Limitation (AVCAL) Study Group. Australian trial of non-invasive Ventilation in Chronic
Airflow Limitation (AVCAL) Study Group. Nocturnal non-invasive nasal ventilation in stable
hypercapnic COPD: a randomized controlled trial. Thorax. 2009;64(7):561–6. doi:
1136/thx.2008.108274, PMID 19213769.
Mehran RJ, Deslauriers J. Indications for surgery and patient workup for bullectomy. Chest Surg
Clin N Am. 1995;5(4):7. Laros CD, Gelissen HJ, Bergstein PG, Van den Bosch JM,
Vanderschueren RG, Westermann CJ, Knaepen PJ. Bullectomy for giant bullae in emphysema. J
Thorac Cardiovasc Surg. 1986;91(1):63–70. PMID 3941561.
Fessler HE, Permutt S. Lung volume reduction surgery and airflow limitation. Am J Respir Crit
Care Med. 1998;157(3 Pt 1):715–22. doi: 10.1164/ajrccm.157.3.9608004, PMID 9517581
DOI: https://doi.org/10.37628/ijcn.v7i1.1840
Refbacks
- There are currently no refbacks.